Total Payments
$19,374
2024 Payments
$2,719
Companies
46
Transactions
910
Medicare Patients
5,151
Medicare Billing
$6.3M
Payment Breakdown by Category
Food & Beverage$18,006 (92.9%)
Other$1,125 (5.8%)
Education$242.58 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,006 | 896 | 92.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,125 | 1 | 5.8% |
| Education | $242.58 | 13 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,948 | 116 | $0 (2024) |
| Amgen Inc. | $2,769 | 131 | $0 (2024) |
| Horizon Therapeutics plc | $1,614 | 83 | $0 (2023) |
| Janssen Biotech, Inc. | $1,445 | 66 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,414 | 62 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,158 | 68 | $0 (2024) |
| PFIZER INC. | $1,033 | 59 | $0 (2024) |
| Lilly USA, LLC | $1,032 | 55 | $0 (2024) |
| UCB, Inc. | $594.45 | 31 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $516.87 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,719 | 107 | Amgen Inc. ($467.61) |
| 2023 | $3,362 | 124 | Horizon Therapeutics plc ($409.42) |
| 2022 | $2,553 | 118 | Amgen Inc. ($439.10) |
| 2021 | $2,385 | 134 | Horizon Therapeutics plc ($418.39) |
| 2020 | $1,488 | 91 | Amgen Inc. ($299.42) |
| 2019 | $2,153 | 123 | Amgen Inc. ($381.36) |
| 2018 | $1,838 | 115 | Novartis Pharmaceuticals Corporation ($262.66) |
| 2017 | $2,876 | 98 | AbbVie, Inc. ($1,342) |
All Payment Transactions
910 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Immunology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $35.25 | General |
| Category: Immunology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.46 | General |
| 12/11/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: Biosimilars | ||||||
| 12/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/25/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Immunology | ||||||
| 11/04/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/28/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Rheumatology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Bioventus LLC | SUPARTZ FX SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: DEVICES | ||||||
| 10/10/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $29.96 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Immunology | ||||||
| 09/30/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Rheumatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,088 | 103,658 | $7.8M | $1.2M |
| 2022 | 20 | 1,161 | 120,580 | $8.9M | $1.5M |
| 2021 | 23 | 1,533 | 137,190 | $11.1M | $2.2M |
| 2020 | 22 | 1,369 | 87,206 | $6.5M | $1.4M |
Total Patients
5,151
Total Services
448,634
Medicare Billing
$6.3M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 69 | 48,820 | $4.0M | $507,158 | 12.8% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 16 | 6,925 | $1.2M | $233,416 | 18.8% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 12 | 36,800 | $1.0M | $144,054 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 409 | 944 | $235,167 | $90,199 | 38.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 47 | 3,900 | $254,046 | $71,058 | 28.0% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 53 | 4,825 | $723,750 | $64,152 | 8.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 109 | 449 | $157,028 | $48,822 | 31.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 70 | 260 | $86,650 | $17,589 | 20.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 54 | 215 | $34,452 | $13,070 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $15,673 | $5,752 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 78 | $14,550 | $5,080 | 34.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 17 | 88 | $8,625 | $2,071 | 24.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 17 | 72 | $5,628 | $1,727 | 30.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 32 | $7,580 | $1,312 | 17.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 17 | $2,565 | $913.57 | 35.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 39 | $5,850 | $455.44 | 7.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 48 | 77 | $1,925 | $442.17 | 23.0% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 17 | 72 | $1,440 | $59.11 | 4.1% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 66 | 50,124 | $4.1M | $584,692 | 14.3% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 20 | 10,776 | $2.0M | $372,300 | 19.0% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 14 | 48,400 | $1.3M | $218,261 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 411 | 926 | $204,547 | $92,197 | 45.1% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2022 | 51 | 4,585 | $690,998 | $86,136 | 12.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 47 | 4,080 | $266,061 | $70,057 | 26.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 94 | 429 | $64,358 | $24,971 | 38.8% |
About Dr. Cory Conniff, MD
Dr. Cory Conniff, MD is a Rheumatology healthcare provider based in Orland Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376539726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cory Conniff, MD has received a total of $19,374 in payments from pharmaceutical and medical device companies, with $2,719 received in 2024. These payments were reported across 910 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($18,006).
As a Medicare-enrolled provider, Conniff has provided services to 5,151 Medicare beneficiaries, totaling 448,634 services with total Medicare billing of $6.3M. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Orland Park, IL
- Active Since 09/21/2005
- Last Updated 11/04/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376539726
Products in Payments
- KRYSTEXXA (Biological) $1,819
- Enbrel (Biological) $1,634
- ORENCIA (Biological) $1,135
- SIMPONI ARIA (Biological) $1,104
- XELJANZ (Drug) $975.55
- TALTZ (Drug) $936.75
- COSENTYX (Biological) $727.21
- ACTHAR (Biological) $599.96
- Humira (Biological) $583.96
- Cimzia (Drug) $570.71
- RINVOQ (Biological) $535.00
- PURIFIED CORTROPHIN GEL (Drug) $427.99
- COSENTYX (Drug) $355.55
- KRYSTEXXA (Drug) $325.50
- SKYRIZI (Biological) $322.01
- STRENSIQ (Biological) $288.10
- TREMFYA (Drug) $259.28
- Prolia (Biological) $236.22
- Rituxan (Biological) $228.65
- OFEV (Drug) $226.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Orland Park
Dr. Fariha Kausar, Md, MD
Rheumatology — Payments: $8,622
Rheumatology $8,622
Dr. Olga Vila-Sola, Md, MD
Rheumatology — Payments: $5,846
Rheumatology $5,846
Dr. Claudia Vergara, M.d, M.D
Rheumatology — Payments: $4,331
Rheumatology $4,331
Dr. Sunil John, Md, MD
Rheumatology — Payments: $4,054
Rheumatology $4,054
Laisvyde Smajkic, Md, MD
Rheumatology — Payments: $364.59
Rheumatology $364.59